Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wayne, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aclaris Therapeutics, Inc. has filed 849 SEC EDGAR filings since 10 Sep 2012

SEC filing history

Showing 101-125 of 149 matching filings.

Per page
25
Current page
5
8-K File 001-37581

8-K

Filing date
08 Feb 2019
Reporting date
08 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-37581

8-K/A

Filing date
18 Jan 2019
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
20 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
17 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
03 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
31 Oct 2018
Reporting date
31 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
18 Oct 2018
Reporting date
17 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
15 Oct 2018
Reporting date
15 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
04 Oct 2018
Reporting date
02 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
03 Aug 2018
Reporting date
03 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
08 Jun 2018
Reporting date
07 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
08 May 2018
Reporting date
08 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
25 Apr 2018
Reporting date
20 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
30 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
15 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
01 Dec 2017
Reporting date
30 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
28 Nov 2017
Reporting date
27 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
09 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
06 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
04 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
11 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .